Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caris Life Sciences, Inc.CAI · Entity 3706 | Director | August 14, 2026 | August 14, 2026 |
| GLAUKOS CorpGKOS · Entity 3510 | PRESIDENT & COO | August 11, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caris Life Sciences, Inc.
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,321 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 13,192 · Balance 29,321 F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
GLAUKOS Corp
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,588 |
Last balance in matching sequence
After 2026-08-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 82,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 2 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 102,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 122,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 4 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 132,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 5 · 2026-08-11 · Sale · Disposed 27,963 · Balance 104,625 F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 6 · 2026-08-11 · Sale · Disposed 32,037 · Balance 72,588 F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 51,475 |
Reported balance
After 2026-08-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 51,475 F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 33,118 |
Reported balance
After 2026-08-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 33,118 F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options.
F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2019 Filed May 17, 2019 21:00 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,647 | $68.50 | $249,819.50 |
DisclosureSEC source: 0001104659-19-030313 · a4.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,063 F2 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 16, 2019 Filed May 17, 2019 21:00 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 3,647 | $41.69 | $152,043.43 |
DisclosureSEC source: 0001104659-19-030313 · a4.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,045 Underlying: Common Stock · 2,500 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to Buy) · Derivative | 103 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,990 Underlying: Common Stock · 103 shares Expires 2027-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,500 | $65.00 | $162,500.00 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,063 F2 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 2,500 | $30.92 | $77,300.00 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 103 | $68.50 | $7,055.50 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,063 F2 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:14 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 103 | $41.69 | $4,294.07 |
DisclosureSEC source: 0001104659-19-029779 · a4.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | OtherStock Options (Right to Buy) · Derivative | 4,010 | $0.00 Strike: $69.30 | $0.00 |
DisclosureSEC source: 0001104659-19-027860 · a4.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,290 Underlying: Common Stock · 4,010 shares Expires 2029-03-14 F6 · kind: Pursuant to the DRO referenced in footnote (3) above, the Reporting Person's economic interest in a portion of this stock option grant is now held by the Reporting Person's former spouse. While these options were retained by the Reporting Person, his former spouse will receive the economic benefit from the portion of the grant representing the former spouse's economic interest, including in connection with exercises thereof and sales of the common stock underlying such portion. Accordingly, the Reporting Person will not report beneficial ownership or dispositions of the portion of the option grant representing the former spouse's economic interest, nor will the Reporting Person report beneficial ownership or acquisitions or dispositions of the underlying common stock, in future Section 16(a) filings. F7 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | OtherStock Options (Right to Buy) · Derivative | 24,955 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001104659-19-027860 · a4.xml · derivative · entry 4 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,545 Underlying: Common Stock · 24,955 shares Expires 2028-03-14 F6 · kind: Pursuant to the DRO referenced in footnote (3) above, the Reporting Person's economic interest in a portion of this stock option grant is now held by the Reporting Person's former spouse. While these options were retained by the Reporting Person, his former spouse will receive the economic benefit from the portion of the grant representing the former spouse's economic interest, including in connection with exercises thereof and sales of the common stock underlying such portion. Accordingly, the Reporting Person will not report beneficial ownership or dispositions of the portion of the option grant representing the former spouse's economic interest, nor will the Reporting Person report beneficial ownership or acquisitions or dispositions of the underlying common stock, in future Section 16(a) filings. F7 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | OtherStock Options (Right to Buy) · Derivative | 111,907 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-19-027860 · a4.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,093 Underlying: Common Stock · 111,907 shares Expires 2027-05-05 F6 · kind: Pursuant to the DRO referenced in footnote (3) above, the Reporting Person's economic interest in a portion of this stock option grant is now held by the Reporting Person's former spouse. While these options were retained by the Reporting Person, his former spouse will receive the economic benefit from the portion of the grant representing the former spouse's economic interest, including in connection with exercises thereof and sales of the common stock underlying such portion. Accordingly, the Reporting Person will not report beneficial ownership or dispositions of the portion of the option grant representing the former spouse's economic interest, nor will the Reporting Person report beneficial ownership or acquisitions or dispositions of the underlying common stock, in future Section 16(a) filings. F7 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | OtherCommon Stock | 23,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027860 · a4.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,063 F3 · kind: In order to comply with the terms of a domestic relations order ("DRO") in connection with a marital dissolution, the Reporting Person's former spouse now holds the economic interest, and the Reporting Person no longer has any pecuniary interest, in the following securities: (i) 5,265 shares of common stock of the Issuer and (2) 18,458 restricted stock units that have not yet vested or been delivered to the Reporting Person, which were previously reported as directly owned by the Reporting Person. While the Reporting Person retains possession of the common stock and restricted stock units until they are sold in connection with the DRO, the Reporting Person's former spouse will receive the economic benefits from, and the Reporting Person will have no discretion with respect to, such securities. (Continued in footnote 4). F4 · kind: Accordingly, the Reporting Person will not report beneficial ownership or dispositions of these securities (including restricted stock units) in future Section 16(a) reports, including to the extent such securities are sold pursuant to a Rule 10b5-1 trading plan that may be adopted by the Reporting Person that includes these securities. Likewise, the number of shares of common stock of the Issuer that may be reported as withheld to satisfy tax obligations in Table 1 will not include the shares withheld with respect to the portion of the restricted stock units representing the former spouse's economic interest. F5 · balance_after: Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 11,219 | $75.64 | $848,605.16 |
DisclosureSEC source: 0001104659-19-027860 · a4.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,786 F1 · kind: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on May 5, 2017, with the vesting schedule in four equal installments on May 5, 2018, May 5, 2019, May 5, 2020 and May 5, 2021. F2 · balance_after: Includes 56,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 23:16 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to Buy) · Derivative | 13,300 | $0.00 Strike: $69.30 | $0.00 |
DisclosureSEC source: 0001104659-19-015710 · a4.xml · derivative · entry 2 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2029-03-14 F3 · derivative.exercise_date: Granted pursuant to the Issuer's 2015 Omnibus Incentive Compensation Plan. Vests over a four-year period, with 25% to vest on the 1st anniversary of the grant date and 1/48th of the total to vest each month thereafter. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 23:16 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 6,311 | $69.30 | $437,352.30 |
DisclosureSEC source: 0001104659-19-015710 · a4.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,005 F1 · security: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. F2 · balance_after: Includes 81,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:19 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 5,000 | $70.03 | $350,150.00 |
DisclosureSEC source: 0001104659-19-009831 · a4.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,694 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The reported amount reflects (1) a transfer of 6,758 shares of Glaukos common stock made by the reporting person pursuant to a domestic relations order exempt from reporting pursuant to Section 16a-12 under the U.S. Securities Exchange Act of 1934, as amended, and (2) 1,335 shares acquired by the reporting person pursuant to the stockholder-approved Glaukos 2015 Employee Stock Purchase Plan. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 22:33 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 5,000 | $60.03 | $300,150.00 |
DisclosureSEC source: 0001562180-18-004746 · primarydocument.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,117 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 23:08 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,100 | $58.37 | $122,577.00 |
DisclosureSEC source: 0001562180-18-004714 · primarydocument.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,117 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $57.405 to $58.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2018 Filed May 14, 2018 23:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 8,883 | $35.80 | $318,011.40 |
DisclosureSEC source: 0001562180-18-002465 · primarydocument.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,217 F1 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on May 5, 2017, with the vesting schedule in four equal installments on May 5, 2018, May 5, 2019, May 5, 2020 and May 5, 2021. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 17:02 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to buy) · Derivative | 80,500 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001562180-18-001646 · primarydocument.xml · derivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,500 Underlying: Common Stock · 80,500 shares Expires 2028-03-14 F1 · derivative.exercise_date: This option vests over a four-year period, with 25% to vest on the first anniversary of the grant date and 1/36th of the total remaining number to vest on a monthly basis thereafter, such that the stock option is vested in full on the fourth anniversary of the grant date. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 18:03 UTC | GLAUKOS Corp GKOS · Entity 3510 | PurchaseCommon Stock | 2,100 | $23.84 | $50,064.00 |
DisclosureSEC source: 0001562180-17-003676 · primarydocument.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,100 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.835 to $23.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2017 Filed May 9, 2017 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001510192-17-000040 · primary_doc.xml · derivative · entry 2 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-05-05 F3 · derivative.exercise_date: Granted pursuant to the Issuer's 2015 Omnibus Incentive Compensation Plan. Vests over a four-year period, with 25% to vest on the 1st anniversary of the grant date and 1/36th of the total remaining number to vest on the last day of each month thereafter. Read SEC document |
| May 05, 2017 Filed May 9, 2017 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-17-000040 · primary_doc.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · CFO, SVP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · security: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. F2 · balance_after: Consists of 100,000 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.